Orexigen Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Orexigen Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 38% to $33,709,000. The net income raised on -$24,524,000 and profit margin reached -73%. Total operating expenses were $156,606,000.
Profit Margin
| 2013 | 3.42M | -77.67M | -2265.78% |
|---|---|---|---|
| 2014 | 55.52M | -37.52M | -67.59% |
| 2015 | 24.45M | -68.68M | -280.83% |
| 2016 | 33.70M | -24.52M | -72.75% |
OREX Income Statement (2013 – 2016)
| 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 33.70M | 24.45M | 55.52M | 3.42M |
Cost of revenue | 7.99M | 0 | 0 | 0 |
Gross profit | 25.71M | 24.45M | 55.52M | 3.42M |
Operating exp. | ||||
Research and development | 38.02M | 40.75M | 57.41M | 56.74M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 156.60M | 84.51M | 86.05M | 80.62M |
Operating income | -56.97M | -60.05M | -30.53M | -77.19M |
Other income (expenses), net | 32.57M | -7.25M | -6.99M | -473K |
Income before tax | -24.39M | -67.31M | -37.52M | -77.67M |
Income tax expense | 133K | 1.37M | 88K | 65K |
Net income | -24.52M | -68.68M | -37.52M | -77.67M |
Earnings per share | ||||
Basic EPS | -1.62 | -4.71 | -0.3 | -0.67 |
Diluted EPS | -1.62 | -0.52 | -0.3 | -0.67 |
| Data source | Data source | Data source | Data source |